Frank Navas, Iii

USPTO Granted Patents = 11 (Patent Applications = 3)

Average Co-Inventor Count = 6.3

ph-index = 3

Forward Citations = 25(Granted Patents)

Company Filing History:

University of North Carolina at Chapel Hill

patents

4. 3 out of 2,198

Smithkline Beecham Corporation

patents

where one patent can have more than one assignee

Years Active: 2005-2024

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12103904 - Benzoylglycine derivatives and methods of making and using same (2024-10-01),

2. 11034649 - Benzoylglycine derivatives and methods of making and using same (2021-06-15),

3. 10550074 - Benzoylglycine derivatives and methods of making and using same (2020-02-04),

4. 8158665 - Farnesoid X receptor agonists (2012-04-17),

5. 7960552 - Farnesoid X receptor agonists (2011-06-14),

6. 7799828 - Cycloalkylidene compounds as modulators of estrogen receptor (2010-09-21),

7. 7705028 - Farnesoid X receptor agonists (2010-04-27),

8. 7649093 - Naphthalene compounds as selective estrogen receptor modulators (2010-01-19),

9. 7569601 - Cycloalkylidene compounds as modulators of estrogen receptor (2009-08-04),

10. 7560589 - Cycloalkylidene compounds as modulators of estrogen receptor (2009-07-14),

11. 6884801 - Imidazoline derivatives as alpha-1A adrenoceptor ligands (2005-04-26),

Title: The Innovative Contributions of Frank Navas, III

Introduction

Frank Navas, III, located in Durham, NC, is a distinguished inventor known for his significant contributions to the field of pharmaceuticals. With an impressive portfolio of 11 patents, he has developed innovative solutions aimed at combating serious health challenges, particularly infections caused by Gram-negative bacteria.

Latest Patents

Among his latest patents are groundbreaking work on benzoylglycine derivatives. These patents disclose compounds that can be formulated in various ways, aimed at providing effective treatments for Gram-negative bacterial infections. The compounds involve complex chemical structures defined by specific variables, showcasing Navas's expertise in synthesis and pharmacology. The methods described in these patents provide a detailed blueprint for their manufacture and application in therapeutic settings.

Career Highlights

Throughout his career, Frank Navas, III has made notable contributions while working at prominent companies such as GlaxoSmithKline LLC and SmithKline Beecham Corporation. His experience at these organizations has undoubtedly shaped his innovative mindset and fostered the development of his patented inventions.

Collaborations

Navas has collaborated with talented professionals, including Jing Fang and Dennis Heyer. These partnerships have contributed to his ability to create impactful inventions and further advance the field of medicinal chemistry.

Conclusion

Frank Navas, III is a remarkable inventor whose work continues to influence the world of pharmaceuticals. His extensive portfolio of patents, particularly in the area of benzoylglycine derivatives, highlights his commitment to innovation and the ongoing battle against microbial infections. As he continues to push the boundaries of science and technology, the medical community stands to benefit immensely from his contributions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

3 patents pending:

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.